Osteoblast specific Y1 receptor deletion enhances bone mass

Bone

Volumn 48, Issue 3, 2011, Pages 461-467

  Lee, Nicola J ^a   Nguyen, Amy D ^a   Enriquez, Ronaldo F ^a   Doyle, Kharen L ^a,b   Sainsbury, Amanda ^a,b   Baldock, Paul A ^a,b   Herzog, Herbert ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bone; Neuropeptide Y; Osteoblast; Y1 receptor

Indexed keywords

ALKALINE PHOSPHATASE; DENTIN MATRIX PROTEIN 1; MESSENGER RNA; NEUROPEPTIDE Y1 RECEPTOR; OSTEOBLAST SPECIFIC Y1 RECEPTOR; OSTEOCALCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE MINERALIZATION; CANCELLOUS BONE; CELL ACTIVITY; CONTROLLED STUDY; GENE DELETION; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; SIGNAL TRANSDUCTION; TRABECULAR BONE; UPREGULATION;

ADIPOSITY; ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; CELL DIFFERENTIATION; DENSITOMETRY; EXTRACELLULAR MATRIX PROTEINS; GENE DELETION; MICE; ORGAN SIZE; ORGAN SPECIFICITY; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; RECEPTORS, NEUROPEPTIDE Y; UP-REGULATION; X-RAY MICROTOMOGRAPHY;

EID: 79751528718     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.10.174     Document Type: Article

References (37)

1. Bruyere O., Varela A.R., Adami S., Detilleux J., Rabenda V., Hiligsmann M., et al. Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women. Eur J Epidemiol 2009, 24:707-712.
2. Siris E.S., Miller P.D., Barrett-Connor E., Faulkner K.G., Wehren L.E., Abbott T.A., et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001, 286:2815-2822.
3. Baldock P.A., Allison S.J., Lundberg P., Lee N.J., Slack K., Lin E.J., et al. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem 2007, 282:19092-19102.
4. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M., et al. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002, 109:915-921.
5. Kaga T., Fujimiya M., Inui A. Emerging functions of neuropeptide Y Y(2) receptors in the brain. Peptides 2001, 22:501-506.
6. Wahlestedt C., Hakanson R. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and postjunctional receptors be distinguished?. Med Biol 1986, 64:85-88.
7. Lee N.J., Doyle K.L., Sainsbury A., Enriquez R.F., Hort Y.J., Riepler S.J., Baldock P.A., Herzog H. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity. J Bone Miner Res. 2010, 25:1736-1747.
8. Eva C., Serra M., Mele P., Panzica G., Oberto A. Physiology and gene regulation of the brain NPY Y1 receptor. Front Neuroendocrinol 2006, 27:308-339.
9. Matsuda H., Brumovsky P.R., Kopp J., Pedrazzini T., Hokfelt T. Distribution of neuropeptide Y Y1 receptors in rodent peripheral tissues. J Comp Neurol 2002, 449:390-404.
10. Lundberg P., Allison S.J., Lee N.J., Baldock P.A., Brouard N., Rost S., et al. Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 2007, 282:19082-19091.
11. Igwe J.C., Jiang X., Paic F., Ma L., Adams D.J., Baldock P.A., et al. Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity. J Cell Biochem 2009, 108:621-630.
12. Baldock P.A., Lee N.J., Driessler F., Lin S., Allison S., Stehrer B., et al. Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS ONE 2009, 4:e8415.
13. Liu F., Woitge H.W., Braut A., Kronenberg M.S., Lichtler A.C., Mina M., et al. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int J Dev Biol 2004, 48:645-653.
14. Baldock P.A., Sainsbury A., Allison S., Lin E.J., Couzens M., Boey D., et al. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways. J Bone Miner Res 2005, 20:1851-1857.
15. Zhang L., Lee N.J., Nguyen A.D., Enriquez R.F., Riepler S.J., Stehrer B., et al. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation. Diab Obes Metab 2009.
16. Kushi A., Sasai H., Koizumi H., Takeda N., Yokoyama M., Nakamura M. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc Natl Acad Sci USA 1998, 95:15659-15664.
17. Pedrazzini T., Seydoux J., Kunstner P., Aubert J.F., Grouzmann E., Beermann F., et al. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 1998, 4:722-726.
18. Baek W.Y., de Crombrugghe B., Kim J.E. Postnatally induced inactivation of osterix in osteoblasts results in the reduction of bone formation and maintenance. Bone 2010, 46:920-928.
19. Liu W., Toyosawa S., Furuichi T., Kanatani N., Yoshida C., Liu Y., et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 2001, 155:157-166.
20. Ozcivici E., Luu Y.K., Adler B., Qin Y.X., Rubin J., Judex S., et al. Mechanical signals as anabolic agents in bone. Nat Rev Rheumatol 2010, 6:50-59.
21. Thrailkill K.M., Lumpkin C.K., Bunn R.C., Kemp S.F., Fowlkes J.L. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005, 289:E735-E745.
22. Fulzele K., Riddle R.C., DiGirolamo D.J., Cao X., Wan C., Chen D., et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010, 142:309-319.
23. Gallagher J.C. Advances in bone biology and new treatments for bone loss. Maturitas 2008, 60:65-69.
24. Amano S., Arai M., Goto S., Togari A. Inhibitory effect of NPY on isoprenaline-induced osteoclastogenesis in mouse bone marrow cells. Biochim Biophys Acta 2007, 1770:966-973.
25. Teixeira L., Sousa D.M., Nunes A.F., Sousa M.M., Herzog H., Lamghari M. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors. J Cell Biochem 2009, 107:908-916.
26. Atkins G.J., Kostakis P., Pan B., Farrugia A., Gronthos S., Evdokiou A., et al. RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 2003, 18:1088-1098.
27. Wheway J., Mackay C.R., Newton R.A., Sainsbury A., Boey D., Herzog H., et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 2005, 202:1527-1538.
28. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
29. Kalariti N., Koutsilieris M. Glutamatergic system in bone physiology. In Vivo 2004, 18:621-628.
30. Ofek O., Karsak M., Leclerc N., Fogel M., Frenkel B., Wright K., et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 2006, 103:696-701.
31. Ahmed M., Bjurholm A., Kreicbergs A., Schultzberg M. Neuropeptide Y, tyrosine hydroxylase and vasoactive intestinal polypeptide-immunoreactive nerve fibers in the vertebral bodies, discs, dura mater, and spinal ligaments of the rat lumbar spine. Spine 1993, 18:268-273.
32. Bjurholm A., Kreicbergs A., Terenius L., Goldstein M., Schultzberg M. Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. J Auton Nerv Syst 1988, 25:119-125.
33. Sisask G., Bjurholm A., Ahmed M., Kreicbergs A. The development of autonomic innervation in bone and joints of the rat. J Auton Nerv Syst 1996, 59:27-33.
34. Ahmed M., Srinivasan G.R., Theodorsson E., Bjurholm A., Kreicbergs A. Extraction and quantitation of neuropeptides in bone by radioimmunoassay. Regul Pept 1994, 51:179-188.
35. Blomqvist A.G., Herzog H. Y-receptor subtypes-how many more?. Trends Neurosci 1997, 20:294-298.
36. Utz A.L., Lawson E.A., Misra M., Mickley D., Gleysteen S., Herzog D.B., et al. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 2008, 43:135-139.
37. Wortley K.E., Garcia K., Okamoto H., Thabet K., Anderson K.D., Shen V., et al. Peptide YY regulates bone turnover in rodents. Gastroenterology 2007, 133:1534-1543.